Literature DB >> 6821838

Establishment and characterization of a carcinoembryonic antigen (CEA)-producing cell line from a human carcinoma of the exocrine pancreas.

T Okabe, N Yamaguchi, N Ohsawa.   

Abstract

A human carcinoembryonic antigen (CEA)-producing cell line, T3M-4, has been established from explant cultures of a primary human pancreatic exocrine adenocarcinoma transplanted into nude mice. The tumor had metastasized in the patient. The tumor obtained from metastatic lymph nodes was the initial source for implantation in athymic nude mice. In the primary culture, host fibroblasts were eliminated by the use of the antiserum raised against nude mouse cells. T3M-4 cells have been continuously propagated in vitro during the past 26 months. The cells grew in a monolayered sheet with about 31 hours of population doubling time. The cells exhibited epithelial morphologic features resembling the structure of the original tumor, and they showed tumor takes when inoculated into athymic nude mice. Xenografts established from the cell line have retained a similar histology to the original tumor on serial transplantation. Chromosomal analysis revealed the cell line to be a human aneuploid one with a hyperdiploid mode. T3M-4 cells possess the characteristic function of CEA secretion in vitro in culture and in vivo in nude mice bearing the tumors produced by inoculation with the cultured cells. In view of these characteristics, T3M-4 cell line represents a new human pancreatic exocrine adenocarcinoma cell line that produces CEA.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6821838     DOI: 10.1002/1097-0142(19830215)51:4<662::aid-cncr2820510419>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  33 in total

1.  Efficient dose-dependent and time-dependent protein transduction of pancreatic carcinoma cells in vitro and in vivo using purified VP22-EGFP fusion protein.

Authors:  Lars Boenicke; Kang Chu; Regina Pauls; Claudia Tams; Marie-Luise Kruse; Roland Kurdow; Bodo Schniewind; Arnd Böhle; Bernd Kremer; Holger Kalthoff
Journal:  J Mol Med (Berl)       Date:  2003-03-18       Impact factor: 4.599

2.  Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle.

Authors:  J J Smith; R Derynck; M Korc
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

3.  Evolution, expression, and chromosomal location of a novel receptor tyrosine kinase gene, eph.

Authors:  Y Maru; H Hirai; M C Yoshida; F Takaku
Journal:  Mol Cell Biol       Date:  1988-09       Impact factor: 4.272

4.  Blood-group antigen expression during pancreatic cancer induction in hamsters.

Authors:  P M Pour; E Uchida; D A Burnett; Z Steplewski
Journal:  Int J Pancreatol       Date:  1986-12

5.  A new human pancreatic carcinoma cell line developed for adoptive immunotherapy studies with lymphokine-activated killer cells in nude mice.

Authors:  B J Drucker; F M Marincola; D Y Siao; T A Donlon; C D Bangs; W D Holder
Journal:  In Vitro Cell Dev Biol       Date:  1988-12

6.  A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile.

Authors:  Paolo Monti; Federica Marchesi; Michele Reni; Alessia Mercalli; Valeria Sordi; Alessandro Zerbi; Giampaolo Balzano; Valerio Di Carlo; Paola Allavena; Lorenzo Piemonti
Journal:  Virchows Arch       Date:  2004-07-17       Impact factor: 4.064

7.  Establishment of a human carcinoembryonic antigen (CEA)-producing cell line in a protein-free chemically defined medium.

Authors:  N Yamaguchi; T Okabe; K Kawai
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

8.  Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling.

Authors:  Megan Moerdyk-Schauwecker; Nirav R Shah; Andrea M Murphy; Eric Hastie; Pinku Mukherjee; Valery Z Grdzelishvili
Journal:  Virology       Date:  2012-12-14       Impact factor: 3.616

9.  Bile acids-mediated overexpression of MUC4 via FAK-dependent c-Jun activation in pancreatic cancer.

Authors:  Suhasini Joshi; Eric Cruz; Satyanarayana Rachagani; Sushovan Guha; Randall E Brand; Moorthy P Ponnusamy; Sushil Kumar; Surinder K Batra
Journal:  Mol Oncol       Date:  2016-04-29       Impact factor: 6.603

10.  A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform.

Authors:  Bence Sipos; Simone Möser; Holger Kalthoff; Virag Török; Matthias Löhr; Günter Klöppel
Journal:  Virchows Arch       Date:  2003-04-12       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.